← Back to Clinical Trials
Recruiting NCT04804748

The DefiPace Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Post-operative Atrial Fibrillation POAF
Sponsor Institut für Pharmakologie und Präventive Medizin
Study Type OBSERVATIONAL
Phase N/A
Enrollment 450
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-03-28
Completion 2026-05-31
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Prospective, non-interventional, multi-center, international registry in two phases in consecutive patients undergoing elective cardiac surgery. The DefiPace registry is designed in two phases 1. to document the standard of care in 50 patients with atrial fibrillation (AF) 2. to assess the treatment and outcomes of patients with post-operative atrial fibrilllation using low-energy cardioversion and subsequent bi-atrial pacing in clinical practice in 100 patients

Eligibility Criteria

Inclusion Criteria: * Patient is scheduled to undergo elective open chest cardiac surgery (bypass and / or valve surgery) * Patient is at least 18 years old * Patient with isolated bypass surgery is at least 70 years old * Patient with valve surgery is at least 60 years old * Patient provides written informed consent prior to the procedure * Phase B only: patient is scheduled for TMA implantation during the elective cardiac surgery and is potentially eligible for DefiPace use Exclusion Criteria: * Clinical history of either permanent, persistend or paroxysmal atrial fibrillation * Permanent pacemaker/defibrillator, other intra-cardiac active implanted electronic devices * Minimally-invasive surgery * Recent stroke within the last 3 months * A history of or current endocarditis * Pregnacy at the time of surgery

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}